Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2009-06-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
NCT01982123
Functional Imaging in Lung SBRT
NCT03121300
Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
NCT02528942
Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
NCT00002577
Radiation Pneumonitis After SBRT for NSCLC
NCT02428049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lung Radiation
Patients with tumors in the lung that require radiation therapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No prior or future planned surgery for the treatment of the lung cancer.
* Age ≥ 18 years
* Karnofsky 60%
* Not pregnant.
* Ability to understand and the willingness to sign a written informed consent document
* Ability and willingness to participate in breathing training and compliance wiht breathing apparatus so that radiation doses are optimally linked to 4D-CT images
* Ability to tolerate CT contrast
Exclusion Criteria
* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
* Pregnant women
* Severe COPD that requires chronic prednisone or multiple inhalers
* Underlying collagen vascular disease or intrinsic lung disease that could complicate expected sequelae of radiation (idiopathic pulmonary fibrosis, Wegener's granulomatosis)
* Oxygen dependence at baseline
* Recent lung surgery or abdominal surgery (within 3 weeks) that would compromise respiratory pattern.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Iowa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John M. Buatti
Professor and Chair, Radiation Oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Bayouth, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Johm M. Buatti, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Iowa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa Department of Radiation Oncology
Iowa City, Iowa, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
200905703
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.